Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.
about
Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prFunctional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene.Inflammatory and oxidative stress in rotavirus infectionCyclooxygenase in the treatment of glioma: its complex role in signal transductionClinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumoursCyclooxygenase-1 as the main source of proinflammatory factors after sodium orthovanadate treatmentAnticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of SnailPossible role of PPARγ in the negative regulation of ovulatory cascade and luteal development in rats.Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomasPrenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure.Polyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells.Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells.Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases.Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation.15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.Nuclear receptors as therapeutic targets for Alzheimer's diseasePPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.Commensal Streptococcus salivarius Modulates PPARγ Transcriptional Activity in Human Intestinal Epithelial Cells.Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradationActivating enhancer-binding protein-2α induces cyclooxygenase-2 expression and promotes nasopharyngeal carcinoma growth.The role of peroxisome proliferator-activated receptors in pulmonary vascular disease.Vitamin E and immune response in the aged: molecular mechanisms and clinical implications.The role of mitogen-activated protein kinases and sterol receptor coactivator-1 in TGF-β-regulated expression of genes implicated in macrophage cholesterol uptakeThe role of peroxisome proliferator-activated receptors in colorectal cancer.Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer.Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.Inflammation and lung carcinogenesis: applying findings in prevention and treatment.Sulindac derivatives that activate the peroxisome proliferator-activated receptor gamma but lack cyclooxygenase inhibition.Peroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosisHuman T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes.Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placentaPPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.Genome-wide analysis of the rat colon reveals proximal-distal differences in histone modifications and proto-oncogene expression.Inhibition of rotavirus ECwt infection in ICR suckling mice by N-acetylcysteine, peroxisome proliferator-activated receptor gamma agonists and cyclooxygenase-2 inhibitors.PPARgamma as a potential therapeutic target in pulmonary hypertension.
P2860
Q21245560-5FE3847F-EF49-4BDB-A80C-521B6ECADDDCQ24812924-FF5F2D26-A0EC-4CC2-8076-D1841F0DB4A1Q25257455-20EC6544-75F9-4D16-A6BB-D8E973C4015AQ26749801-FEB7A3EB-B029-452E-B3D9-D240A141AAA3Q28168685-B4B74E51-469A-4DA6-B803-CF062C88FFA4Q28209267-21ACFBD7-94B1-4792-90E4-267C758D5280Q28652149-69395F10-22F2-47B0-8D6C-4FD7BEB990CDQ33692555-2DA6CC00-E554-4261-82AB-0223A3E8523BQ33727031-07E1223C-7DB2-4A60-8F12-398EC0B48F21Q33844072-E0E6E2A8-E33B-4A53-92A6-6E2731241481Q34246553-007F6F6D-8D77-4FE2-B64D-99709DDC7450Q34289032-B7291A7C-870F-4F3A-BA2F-8AEA157E93FCQ34300048-4928EA17-C7AF-4B61-B9DE-E1E6A008C881Q34335269-6295E0FE-4FBB-4C32-81EF-AE1D0733521EQ34580424-A5F1613C-CE38-46AE-9274-96E9DE646CAAQ34986711-07B38DDA-C712-43B9-89AC-90076ED3822DQ35080524-51F609AE-DB3D-4C51-9162-0F1ED4E6997FQ35165186-78C31938-A4EA-4728-B142-9EFABC0B5837Q35216293-C63644A0-A5C5-497F-B873-F2009CC981C8Q35458969-B4148CCA-4D8A-4DF6-9DB2-CABD026B555EQ35623144-5E8908E7-66C4-425B-AC0C-F6C5AA014AEEQ35660728-3B372E90-74CA-4625-A062-B8B655AE5E46Q35741600-12D7B98E-6715-4E24-B130-403C30D1DFF3Q35925357-CBA0D777-61CB-4056-94A0-ED872393E1CCQ36121078-C3376346-10AA-4722-8A42-2F12C7DF186FQ36149170-FFB4DAA7-9536-49E5-BD35-4C892DE1CEC2Q36248494-A3E8FAD0-02FD-4BE7-9AAB-5BB47E0F675EQ36591722-3BBADDDF-F415-4A8A-B7EC-E0E0D45281B0Q36747305-09B526C5-D615-40F5-90B0-F77E15D983ECQ36959883-A6BD726F-A6BB-47E0-ADBC-488FF23B5994Q36974700-53DD0824-CABF-454B-BC7C-76ED183B5A6AQ37118687-18268513-EF33-482B-ACE1-7664EA48637EQ37142538-2B4BC84E-FE43-443A-A0A4-AB40CA7838BCQ37146010-41A38687-BD44-413C-89CD-1CCBABAF0425Q37156360-065D9C66-34AF-42E7-A647-F4EC5239A38BQ37188544-CEE73B25-A969-4337-BC4B-B17F79D631B7Q37215869-42434A6E-8CAE-4BB0-BDF5-9A27DB0F4785Q37440936-1A61E407-7B2E-4C68-8412-24598EABEF04Q37675315-C9F56167-261B-47AC-B187-639310487D5AQ37689190-33273963-F568-42CE-83D6-9AAD3828DA68
P2860
Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Peroxisome proliferator-activa ...... and CREB-binding protein/p300.
@en
type
label
Peroxisome proliferator-activa ...... and CREB-binding protein/p300.
@en
prefLabel
Peroxisome proliferator-activa ...... and CREB-binding protein/p300.
@en
P2093
P356
P1476
Peroxisome proliferator-activa ...... and CREB-binding protein/p300.
@en
P2093
A J Dannenberg
K Subbaramaiah
P304
12440-12448
P356
10.1074/JBC.M007237200
P407
P577
2001-01-23T00:00:00Z